Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Mihai Merzianu, MD, Richard Cheney, MD, Adrienne Groman, MS, George Deeb, MD, Gregory Wilding, PhD, Claudiu Cotta, MD, Ramila Amre, MD, Manjula Balasubramanian, MD, Guilherme Brandao, MD, Russell K. Brynes, MD, Sindhu Cherian, MD, Elizabeth Courville, MD, David Czuchlewski, MD, Guang Fan, MD PhD, David Grier, MD, Daniela Hoehn, MD PhD, Robert E Hutchison, MD, Kedar V. Inamdar, MD PhD, Ridas Juskevicius, MD, Prabhjot Kaur, MD, John Lazarchick, MD, Michael R Lewis, MD, Rodney R. Miles, MD PhD, Jerome B. Myers, MD PhD, Michel Nasr, MD, Hina Naushad, MD, Horatiu Olteanu, MD PhD, Attilio Orazi, MD, Vishnu VB Reddy, MD, Valentin G Robu, MD, Gratian Salaru, MD, Julie Teruya-Feldstein, MD, Neerja Vajpayee, MD, Jeffrey Vos, MD, Ling Zhang, MD, Shanxing Zhang, MD PhD, Ashley V Sedelmeyer, MHA, Vivian Arguello, MD, Le Aye, DO, Sharon Barouk, MA, Elisa F Brega, MD PhD, Richie Carpenter, BS, James E. Coad, MD, Alana DiPonio, MT, Fernandez Garcia, MS, MD, John Grantham, BS, Sinisa Ivelja, MD, Robert McKenna, MD, Kieran Sultan, MD, Matthew B Thomsen, MPH, Jie Xu, MD PhD, LoAnn Peterson, MD, Vishala T. Neppalli, MD

Blood (2014) 124 (21): 1316.

https://doi.org/10.1182/blood.V124.21.1316.1316

Published: 2014

Journal Articles

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Hong Liu, MD, PhD, Theresa Hahn, PhD, Gregory Wilding, PhD, Adrienne Groman, Barbara Bambach, MD, Meghan Higman, MD, Maureen Ross, MD, PhD, George L. Chen, MD, Philip L. McCarthy, Jr., MD

Blood (2011) 118 (21): 4570.

https://doi.org/10.1182/blood.V118.21.4570.4570

Published: 2011

Journal Articles

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

Syed Noor, MD, Wei Tan, PhD, Gregory Wilding, PhD, Laurie Ann Ford, Maurice Barcos, MD, PhD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 3113.

https://doi.org/10.1182/blood.V114.22.3113.3113

Published: 2009

Journal Articles

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Shannon L Smiley, MD, Theresa Hahn, PhD, Wei Tan, MS, Gregory Wilding, PhD, Minoo Battiwalla, MD, Philip L. McCarthy, Jr., MD

Blood (2008) 112 (11): 2176.

https://doi.org/10.1182/blood.V112.11.2176.2176

Published: 2008

Journal Articles

Improving Compliance with Guidelines for Venous Thromboembolism (VTE) Prophylaxis Significantly Reduces VTE Events.

Manmeet S Ahluwalia, MD, Kimberly Klein, RN, RPA-C, Boris W Kuvshinoff, MD, Francisco J. Hernandez-Ilizaliturri, MD, Gregory Wilding, PhD, Judy L. Smith, MD, MS, Minoo Battiwalla, MD

Blood (2008) 112 (11): 1288.

https://doi.org/10.1182/blood.V112.11.1288.1288

Published: 2008

Journal Articles

Biologic Features and Treatment Outcome of Secondary Acute Lymphoblastic Leukemia - Review of 101 Cases.

Ranga Shivakumar, MD, Wei Tan, MS, Gregory Wilding, PhD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2007) 110 (11): 4345.

https://doi.org/10.1182/blood.V110.11.4345.4345

Published: 2007

Journal Articles

Renal Dysfunction Does Not Affect Clinical Response in Multiple Myeloma (MM) Patients Treated with Bortezomib-Based Regimens.

Sikander Ailawadhi, MD, Terry L. Mashtare, PhD, Marie V. Coignet, Dawn M. Depaolo, Kena C. Miller, MSN NP, Gregory Wilding, PhD, Asher Alban Chanan-Khan, MD

Blood (2007) 110 (11): 1477.

https://doi.org/10.1182/blood.V110.11.1477.1477

Published: 2007

Journal Articles

Determining the Extent of Disease with Magnetic Resonance Imaging of the Bone Marrow (BM-MRI) in Patients with Multiple Myeloma (MM).

Sikander Ailawadhi, MD, Lyudmyla Derby, MD, Terry L. Mashtare, PhD, Kena C. Miller, MSN NP, Gregory Wilding, PhD, Swaminathan Padmanabhan, MD, Ronald Gottlieb, MD MPH, Ronald A. Alberico, MD, Donald L. Klippenstein, MD, Ahmed N. Abdelhalim, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 1483.

https://doi.org/10.1182/blood.V110.11.1483.1483

Published: 2007

Journal Articles

bcl-2 Translocation [t(14;18) (q32;q21)] Does Not Correlate with Poor Clinical Outcome in Multiple Myeloma Patients Treated with Bortezomib.

Sikander Ailawadhi, MD, Terry L. Mashtare, PhD, Marie V. Coignet, Dawn M. DePaolo, Kena C. Miller, MSN, NP, Swaminathan Padmanabhan, MD, Gregory Wilding, PhD, Petr Starostik, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 1498.

https://doi.org/10.1182/blood.V110.11.1498.1498

Published: 2007

Journal Articles

Improved Sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in Quantifying the Extent of Bone Marrow Involvement in Patients with Multiple Myeloma (MM).

Sikander Ailawadhi, MD, Lyudmyla Derby, MD, Kena C. Miller, MSN NP, Terry L. Mashtare, PhD, Gregory Wilding, PhD, Swaminathan Padmanabhan, MD, Ronald Gottlieb, MD MPH, Ronald A. Alberico, MD, Donald L. Klippenstein, MD, Ahmed N. Abdelhalim, MD, Asher A. Chanan-Khan, MD

Blood (2007) 110 (11): 4776.

https://doi.org/10.1182/blood.V110.11.4776.4776

Published: 2007

NARROW

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Fludarabine, Melphalan and Low Dose Total Body Irradiation for Reduced Intensity Conditioning (RIC) Prior to Allogeneic Hematopoietic Cell Transplantation (AlloHCT)

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

BuCy Provides Equivalent Outcomes to VCyTBI as Conditioning Prior to Auto-SCT in Patients with Relapsed/Refractory NHL and Is a Valuable Option in Older (≥60 years) Patients.

Improving Compliance with Guidelines for Venous Thromboembolism (VTE) Prophylaxis Significantly Reduces VTE Events.

Biologic Features and Treatment Outcome of Secondary Acute Lymphoblastic Leukemia - Review of 101 Cases.

Renal Dysfunction Does Not Affect Clinical Response in Multiple Myeloma (MM) Patients Treated with Bortezomib-Based Regimens.

Determining the Extent of Disease with Magnetic Resonance Imaging of the Bone Marrow (BM-MRI) in Patients with Multiple Myeloma (MM).

bcl-2 Translocation [t(14;18) (q32;q21)] Does Not Correlate with Poor Clinical Outcome in Multiple Myeloma Patients Treated with Bortezomib.

Improved Sensitivity of Bone Marrow Magnetic Resonance Imaging (BM-MRI) in Quantifying the Extent of Bone Marrow Involvement in Patients with Multiple Myeloma (MM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only